Papers

1

Total Citations

32

H-Index

1

About

Zizhen Qing is a prominent urological surgeon and researcher whose work centers on advancing surgical techniques for prostate cancer treatment, with a particular focus on optimizing patient quality of life. His most cited study, a 2021 meta-analysis comparing Retzius-sparing and conventional robot-assisted laparoscopic radical prostatectomy, has garnered 32 citations and significantly shaped clinical practice. This work systematically demonstrated that the Retzius-sparing approach offers superior early postoperative continence and sexual function outcomes without compromising oncological safety, providing crucial evidence for surgeons selecting surgical approaches. Qing’s research bridges the gap between technical innovation and patient-centered outcomes, addressing the critical trade-offs between cancer control and functional preservation. His contributions have been widely cited in urology guidelines and surgical training curricula, reflecting their practical impact. By rigorously evaluating emerging techniques through meta-analytic methods, Qing has helped establish evidence-based standards for minimally invasive prostate surgery, ultimately improving recovery experiences for thousands of patients worldwide. His work continues to influence debates on surgical precision and quality-of-life metrics in uro-oncology.

Research Focus

Key Achievements

1
H-Index
1
Papers
32
Total Citations
32
Avg Citations/Paper
🏆 Most Cited Paper
Comparison of Retzius-sparing and conventional robot-assisted laparoscopic radical prostatectomy regarding continence and sexual function: an updated meta-analysis
32 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: First Affiliated Hospital of Chongqing Medical University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago